Open Access. Powered by Scholars. Published by Universities.®
Zucker School of Medicine at Hofstra/Northwell
INFLAMMATORY-BOWEL-DISEASE;; VAGUS NERVE;; ULCERATIVE-COLITIS;; ANTIINFLAMMATORY PATHWAY;; INTESTINAL INFLAMMATION;; CROHNS-DISEASE;; MURINE MODEL;; KAPPA-B;; CYTOKINES;; NICOTINE;; Multidisciplinary Sciences
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Central Muscarinic Cholinergic Activation Alters Interaction Between Splenic Dendritic Cell And Cd4(+)Cd25(-) T Cells In Experimental Colitis, P. Munyaka, M. F. Rabbi, V. A. Pavlov, K. J. Tracey, E. Khafipour, J. E. Ghia
Central Muscarinic Cholinergic Activation Alters Interaction Between Splenic Dendritic Cell And Cd4(+)Cd25(-) T Cells In Experimental Colitis, P. Munyaka, M. F. Rabbi, V. A. Pavlov, K. J. Tracey, E. Khafipour, J. E. Ghia
Journal Articles
Background: The cholinergic anti-inflammatory pathway (CAP) is based on vagus nerve (VN) activity that regulates macrophage and dendritic cell responses in the spleen through alpha-7 nicotinic acetylcholine receptor (a7nAChR) signaling. Inflammatory bowel disease (IBD) patients present dysautonomia with decreased vagus nerve activity, dendritic cell and T cell over-activation. The aim of this study was to investigate whether central activation of the CAP alters the function of dendritic cells (DCs) and sequential CD4(+)/CD25(-)T cell activation in the context of experimental colitis. Methods: The dinitrobenzene sulfonic acid model of experimental colitis in C57BL/6 mice was used. Central, intracerebroventricular infusion of the M1 …